Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease

Liver Int. 2020 Oct;40(10):2569-2570. doi: 10.1111/liv.14564. Epub 2020 Jul 5.

Authors

Ling Xu^{1

2}, Jia Liu^{1

2}, Mengji Lu^{2

3}, Dongliang Yang^{1

2}, Xin Zheng^{1

2}

Affiliations

¹ Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
³ Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.

No abstract available

Keywords: COVID-19; liver injury; metabolic (dysfunction)-associated fatty liver disease.

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
COVID-19*
Humans
Liver
Non-alcoholic Fatty Liver Disease* / epidemiology
Pandemics